Exploring Functional Genomic Screening In Leiomyosarcoma
Welcome to our comprehensive guide on Functional Genomic Screening In Leiomyosarcoma.
- Jonathan C. Trent, MD, PhD, discusses Rachel, a 58-year-old school teacher from Roanoke, Virginia, diagnosed with ...
- Jonathan C. Trent, MD, PhD, discusses Rachel, a 58-year-old school teacher from Roanoke, Virginia, diagnosed with ...
- Shreyaskumar R. Patel, MD discusses Rachel, a 58-year-old school teacher from Roanoke, Virginia, diagnosed with ...
- In this LabRoots webinar, Derek Welsbie, M.D., Ph.D. (Dept. of Ophthalmology, University of California, San Diego) discusses ...
- Dr. Ravindra Kolhe (AUMC) & Dr. Joanna Przybyl (Stanford Univ.) discuss the importance of copy number in the understanding ...
In-Depth Information on Functional Genomic Screening In Leiomyosarcoma
by Adrián Mariño-Enríquez, MD of of Brigham and Women's Hospital. by Matt van de Rijn, MD, PhD of Stanford University Medical Center. Increase chances of successful clinical trials by performing David Thomas, FRACP, PhD, director and division head,
Presented by Katherine Fuh, MD, PhD Disclosure and CE info at: https://stanford.cloud-cme.com/course/courseoverview?
In summary, understanding Functional Genomic Screening In Leiomyosarcoma gives us a better perspective.
